Menu
← Oncology Approval Tracker
FDA DECISION ·
Zenbexus + Darzalex Faspro + dexamethasone
iberdomide with daratumumab and hyaluronidase-fihj and dexamethasone · Bristol Myers Squibb
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with multiple myeloma who have had at least one prior line that included both a proteasome inhibitor and an immunomodulatory drug.
LAMPGEN ANALYSIS
Why it matters
This adds an iberdomide-based regimen after prior treatment. Keep the endpoint underlying accelerated approval separate from the evidence expected to verify clinical benefit.
What research teams should watch
Capture prior drug-class exposure and resistance in a structured history. The confirmatory program will depend on consistent marrow assessment and follow-up.
PRIMARY RECORDS